Conference Series llc LTD organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 1,00,000 eminent personalities, reputed scientists as editorial board and organizing committee members.  Conference Series llc LTDjournals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing. Conference Series llc LTD Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, international workshops, world class international exhibitions and poster presentations.

STUDY BACKGROUND

While it appears inevitable that nanotechnology will have a broad and fundamental impact on many sectors of the U.S. economy, various technical, marketing and other hurdles need to be overcome before nanotechnology fulfils this promise. These challenges and differences of opinion regarding commercial applications are reflected in the widely diverging estimates of the U.S. and global nanotechnology markets.

Estimates of the global nanotechnology market in 2010 range from about $15.7 billion (the figure used in this report) to $1 trillion. By 2016, the market may be worth more than $2.4 trillion, according to different analysts. These differences reflect not only different analytical methods and assumptions, but also different definitions of the nanotechnology market (e.g., whether to include decades-old technologies such as carbon black rubber reinforces and photographic silver, or whether to base the market value on nanotechnology inputs alone, as opposed to the total value of products that incorporate nanotechnology).

Perhaps as a reflection of the difficulty of quantifying the market for nanotechnologies, some analysts downplay the commercial dimensions of the nanotechnology market, and focus instead on the supply side, i.e., the development of new Nano scale technologies and applications. These analysts have made valuable contributions, raising investors’ awareness of and interest in nanotechnologies.

However, by itself, the work of these analysts does not provide sufficient information in order to guide corporate or individual investment decisions. Investors require additional data, such as the size of specific nanotechnology markets, prices, and competition, as well as potential regulation

SCOPE OF REPORT

 The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

The report talks about the major growth areas of within the nanomedicine market over the period of forecast. The introduction of new technologies and applications in this sector will propel growth to a significant degree at the global level. Further, the initiatives taken by various governments as well as privately-funded institutions towards promoting the commercialization of new nanomedicine products will boost this market. The report also dwells on the role played by the rising geriatric population base, the prevalence of medical needs that are in need of treatment, as well as the rising incidence of chronic diseases globally.

According to the report, the leading application segment within the nanomedicine market was that of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially available products prevail in this sector.

The development of nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.

Though the largest market segment within the nanomedicine market is that of oncology, the fastest growing segment is the cardiovascular market. According to the Transparency Market Research report, growth in this segment has been fuelled by the presence of a sizeable patient population, and a simultaneous growth in the demand for device and drugs that are based on nanomedicine. These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the nanomedicine market.

The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products. According to the report, the nanomedicine market was largely dominated by North America in 2012. It is expected that this regional market will continue to hold its leading position in the way over the forecast period until 2019.

Though the larger market share will be held by North America, it is anticipated that the fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.

Furthermore, the analysis of the regional markets also concludes that the Europe region is predicted to show a growth rate that’s relatively higher than that of North America. Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.

The report on the global nanomedicine market additionally comprises an overview of the key market players in a section dedicated to company profiles. These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.

World renowned speakers, the most recent techniques, tactics and the newest updates along with the advances in the fields of Nanomaterials & Nanotechnology.

Why to attend?

With members from around the world focused on learning about Nanotechnology engineering and Nano medicine this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 2-day event.

World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nanotechnology and engineering, Medical Nanotechnology, tissue engineering are hallmarks of this conference. Medical Nanotechnology-2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanotechnology, Material Science and other interesting topics.

INTENDED AUDIENCE

The report is especially intended for entrepreneurs, investors, venture capitalists, and other readers with a need to know where the nanotechnology market is headed in the next 5 years. Other readers who should find the report particularly valuable include nanotechnology marketing executives and government officials associated with the National Nanotechnology Initiative and other state-level programs that promote the development of the nanotechnology industry. The report’s findings and conclusions should also be of interest to the broader nanotechnology community.

World-renowned speakers, the most recent techniques, tactics and the newest updates along with the Advances in the fields of Nanomaterials & Nanotechnology.

Come be Part of it...!

MEDICAL NANOTECHNOLOGY 2017

Theme: Advances of Nanomedicine in diagnosis theranostics

STUDY BACKGROUND

While it appears inevitable that nanotechnology will have a broad and fundamental impact on many sectors of the U.S. economy, various technical, marketing and other hurdles need to be overcome before nanotechnology fulfills this promise. These challenges and differences of opinion regarding commercial applications are reflected in the widely diverging estimates of the U.S. and global nanotechnology markets.

Estimates of the global nanotechnology market in 2010 range from about $15.7 billion (the figure used in this report) to $1 trillion. By 2016, the market may be worth more than $2.4 trillion, according to different analysts. These differences reflect not only different analytical methods and assumptions, but also different definitions of the nanotechnology market (e.g., whether to include decades-old technologies such as carbon black rubber reinforcers and photographic silver, or whether to base the market value on nanotechnology inputs alone, as opposed to the total value of products that incorporate nanotechnology).

Perhaps as a reflection of the difficulty of quantifying the market for nanotechnologies, some analysts downplay the commercial dimensions of the nanotechnology market, and focus instead on the supply side, i.e., the development of new nanoscale technologies and applications. These analysts have made valuable contributions, raising investors’ awareness of and interest in nanotechnologies.

However, by itself, the work of these analysts does not provide sufficient information in order to guide corporate or individual investment decisions. Investors require additional data, such as the size of specific nanotechnology markets, prices, and competition, as well as potential regulation.

STUDY GOALS AND OBJECTIVES

The goal of this report is to provide investors and others with information on the commercial potential of various nanotechnologies and to complement the growing body of technical information. Specific objectives include identifying segments of the nanotechnology market with the greatest commercial potential in the near to mid-term (2010 through 2015), projecting future demand in these segments, and evaluating the challenges that must be overcome for each segment to realize its potential in order to estimate the probability of successful commercialization.

INTENDED AUDIENCE

 The report is especially intended for entrepreneurs, investors, venture capitalists, and other readers with a need to know where the nanotechnology market is headed in the next 5 years. Other readers who should find the report particularly valuable include nanotechnology marketing executives and government officials associated with the National Nanotechnology Initiative and other state-level programs that promote the development of the nanotechnology industry. The report’s findings and conclusions should also be of interest to the broader nanotechnology community.

Why Osaka?

Global Summit on Medical Nanotechnology is going to be held in Osaka, Japan. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”. With a population of 2.5 million, Osaka is Japan’s third largest and second most important city. It has been the economic powerhouse of the Kansai region for many centuries. The city’s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the Tempozan Harbour Village. The Museum of Oriental Ceramics holds more than 2,000 pieces of ceramics, from China, Korea, Japan and Vietnam, featuring displays of some of their Korean celadon under natural light.

SCOPE OF REPORT

 The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

The report talks about the major growth areas of within the nanomedicine market over the period of forecast. The introduction of new technologies and applications in this sector will propel growth to a significant degree at the global level. Further, the initiatives taken by various governments as well as privately-funded institutions towards promoting the commercialization of new nanomedicine products will boost this market. The report also dwells on the role played by the rising geriatric population base, the prevalence of medical needs that are in need of treatment, as well as the rising incidence of chronic diseases globally.

According to the report, the leading application segment within the nanomedicine market was that of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially available products prevail in this sector.

The development of nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.

Though the largest market segment within the nanomedicine market is that of oncology, the fastest growing segment is the cardiovascular market. According to the Transparency Market Research report, growth in this segment has been fuelled by the presence of a sizeable patient population, and a simultaneous growth in the demand for device and drugs that are based on nanomedicine. These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the nanomedicine market.

The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products. According to the report, the nanomedicine market was largely dominated by North America in 2012. It is expected that this regional market will continue to hold its leading position in the way over the forecast period until 2019.

Though the larger market share will be held by North America, it is anticipated that the fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.

Furthermore, the analysis of the regional markets also concludes that the Europe region is predicted to show a growth rate that’s relatively higher than that of North America. Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.

The report on the global nanomedicine market additionally comprises an overview of the key market players in a section dedicated to company profiles. These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.

Nanomedicine study in various countries:

GLOBAL MARKET

The emergence of nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.Some of thedrivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.

The global nanomedicine market is categorized into six segments on the basis of application, namely neurology, cardiovascular, anti-inflammatory, anti-infective, oncology and others.

Oncology held majority of the market share in 2012 on account of following factors:

• Presence of high number of commercialized nanomedicine products in the market
• Improved bioavailability and efficacy of the tumor specific nanomedicine enabling targeted drug delivery
• Rise in nanomedicine drug formulations replacing conventional drug formulations in cancer treatment

However, the global market for cardiovascular segment is expected to grow at the fastest pace owing to increasing prevalence of cardiovascular diseases demanding drugs with improved efficacy and therapeutic properties. Furthermore, realizing the importance and benefits of nanomedicine, researchers and manufacturers are striving to develop products with improved therapeutic properties in the cardiovascular segment.

The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia–Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region.In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region.China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

Overall research in various disciplines:

REPORT HIGHLIGHTS

The global Nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CA GR) of 14.1% between years 2011 and 2016.

Major Nanotechnology Associations around the Globe

• New England Nanotechnology Association (NENA)
• Asian Nanoscience and Nanotechnology Association
• International Association of Nanotechnology
• American Society for Testing and Materials (ASTM International).
• Nanoscale Science Research Centers (NSRCs)
• Australian Research Council Nanotechnology Network (ARCNN)
• Global Nanotechnology Network (GNN)
• Materials Research Society
• International Union of Materials Research societies

Major Medical Universities

In Asia Pecific

• The University of Tokyo
•   National University of Singapore (NUS)
• Kyoto University
• University of Hong Kong (HKU)
• Peking University
• Seoul National University (SNU)
• National Taiwan University (NTU)
• Osaka University
• Tsinghua University0
• The Chinese University of Hong Kong (CUHK)
• Fudan University
• The Hong Kong University of Science and Technology (HKUST)
• Taipei Medical University
• Mahidol University
• KAIST - Korea Advanced Institute of Science and Technology
• Yonsei University
• Shanghai Jiao Tong University
• Nanyang Technological University (NTU)
• Chulalongkorn University
• Tohoku University
• Tokyo Medical and Dental University
• Kyushu University
• Nagoya University
• Hokkaido University
• Sungkyunkwan University
• University of Science and Technology of China
• Pohang University of Science and Technology (POSTECH)
• Korea University
• Universiti Malaya (UM)
• Zhejiang University
• Keio University
• Indian Institute of Science
• Tokyo Institute of Technology
• Universiti Kebangsaan Malaysia (UKM)
• Universiti Sains Malaysia (USM)
• Beijing University of Chinese Medicine
• National Tsing Hua University
• Nanjing University
• Kyung Hee University
• National Yang Ming University
• University of Indonesia
• University of the Philippines
• University of Tsukuba
• Bandung Institute of Technology (ITB)
• Hanyang University
• Indian Institute of Technology Bombay (IITB)
• National Cheng Kung University
• Universiti Putra Malaysia (UPM)
• Beijing Institute of Technology
• University of Delhi

Top Centres & Hospitals in JAPAN

•       Medical Excellence JAPAN
•       Japan Community Health care Organization Chukyo Hospital
•       Aichi Cancer Center Hospital
•       Japanese Red Cross Nagoya Daiichi Hospital
•       Kyoto University Hospital
•       Dokkyo Medical University Hospital
•       Japan Hospital Association
•       Aizawa Hospital
•       University Hospital Kumamoto University
•       International Medical Center of Japan